(Q34057539)

30 July 2017

1 reference

title

Gastroesophageal reflux disease and Barrett's esophagus. (English)

1 reference

gastroesophageal reflux disease

30 July 2017

main subject

0 references

1 reference

Katzka DA

1

1 reference

30 July 2017

Rustgi AK

series ordinal

2

1 reference

30 July 2017

publication date

1 September 2000

1 reference

Medical Clinics of North America

30 July 2017

published in

1 reference

30 July 2017

volume

84

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

1137-1161

1 reference

Outcome of laparoscopic Nissen fundoplication in patients with disordered preoperative peristalsis.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Oesophageal dysmotility is not associated with poor outcome after laparoscopic Nissen fundoplication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Involvement of cholecystokininA receptors in transient lower esophageal sphincter relaxations triggered by gastric distension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Cholecystokinin in transient lower oesophageal sphincter relaxation due to gastric distension in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Role of the diaphragm in the genesis of lower esophageal sphincter pressure in the cat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

The rumination syndrome: clinical features rather than manometric diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Relationships between the acidity and osmolality of popular beverages and reported postprandial heartburn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Value of Nissen fundoplication in patients with gastro-oesophageal reflux judged by long-term symptom control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal reflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Esophageal acid sensitivity in Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Evaluation of elevation of the head of the bed, bethanechol, and antacid foam tablets on gastroesophageal reflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Omeprazole failure in a patient with gastroesophageal reflux disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Esophageal peristaltic dysfunction in peptic esophagitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Motility abnormalities in gastroesophageal reflux disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Influence of spontaneous sleep positions on nighttime recumbent reflux in patients with gastroesophageal reflux disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Association between body mass and adenocarcinoma of the esophagus and gastric cardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Activation of the GABA(B) receptor inhibits transient lower esophageal sphincter relaxations in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Oesophageal motility before and after laparoscopic Nissen fundoplication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Reliability of 24-hour home esophageal pH monitoring in diagnosis of gastroesophageal reflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Ranitidine versus cimetidine in the healing of erosive esophagitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Reflux esophagitis in patients with Zollinger-Ellison syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Transient lower esophageal sphincter relaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Oesophageal manometry and pH recording does not predict the bad results of Nissen fundoplication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Observer variation in the diagnosis of dysplasia in Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Does oesophageal motor function improve with time after successful antireflux surgery? Results of a prospective, randomised clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Barrett esophagus after chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF): an iatrogenic injury?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Efficacy of twice daily doses of 40 or 20 milligrams famotidine or 150 milligrams ranitidine for treatment of patients with moderate to severe erosive esophagitis. Famotidine Erosive Esophagitis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Determinants of gastroesophageal junction incompetence: hiatal hernia, lower esophageal sphincter, or both?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Barrett's esophagus in children and young adults. Frequent association with mental retardation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Gastroesophageal reflux among severely retardedchildren

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

A comparison of five maintenance therapies for reflux esophagitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

Efficacy and Tolerability of Famotidine in Preventing Heartburn and Related Symptoms of Upper Gastrointestinal Discomfort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970280-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(05)70280-7

1 reference

30 July 2017

1 reference